Adigoside
| Code | Size | Price |
|---|
| TAR-T29658-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Adigoside is a bioactive chemical.
CAS:
14259-51-9
Formula:
C35H54O9
Molecular Weight:
618.808
Purity:
0.98
SMILES:
[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H]([C@H](C[C@]34O)OC(=O)CC(C)C)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@@H](OC)[C@@H](O)[C@@H](C)O1
References
1. Work group of the French Society of Otorhinolaryngology (SFORL). Consensus document for prescription of nebulization in rhinology. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Dec;131(6):371-374. doi: 10.1016/j.anorl.2014.07.004. PubMed PMID: 25456242.
2. Elbeldi A, Smaoui H, Hamouda S, Helel S, Hmaied F, Ben Mustapha I, Barsaoui S, Bousnina S, Marrakchi Z, Barbouche MR, Kechrid A. [Listeriosis in Tunis: seven cases reports]. Bull Soc Pathol Exot. 2011 Feb;104(1):58-61. doi: 10.1007/s13149-010-0110-8. Epub 2010 Dec 20. French. PubMed PMID: 21174237.
3. Guenifi W, Rais M, Gasmi A, Ouyahia A, Boukhrissa H, Mechakra S, Houari M, Nouasria B, Lacheheb A. [Neurobrucellosis: description of 5 cases in Setif Hospital, Algeria]. Med Trop (Mars). 2010 Jun;70(3):309-10. French. PubMed PMID: 20734609.
4. Picot S, Rakotomalala RS, Farny K, Simac C, Michault A. [Evolution of resistance to antibiotics from 1997 to 2005 in the Reunion Island]. Med Mal Infect. 2010 Nov;40(11):617-24. doi: 10.1016/j.medmal.2010.04.001. Epub 2010 May 31. French. PubMed PMID: 20570074.